SHH and medulloblastoma: In the context of medulloblastoma formation and other tumors involving Wnt/β-catenin and SHH signaling mechanisms, such elevated CK1 kinase activity and the loss of its control can lead to hyperstimulation of these signaling pathways, thereby supporting tumor formation.